 | • レポートコード：MRC2301B125 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、255ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に344.32百万ドルであった世界のヘモグロビンA1c分析装置市場規模が、2022年に379.93百万ドルになり、2027年には627.40百万ドルまで、年平均10.51%で成長すると予測しています。本レポートでは、ヘモグロビンA1c分析装置の世界市場について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（ベンチトップ型分析装置、携帯型分析装置、試薬＆消耗品、検査キット）分析、技術別（化学的方法、分離方法）分析、種類別（HbA1c臨床検査、HbA1c PoC検査）分析、エンドユーザー別（学術＆研究機関、病院＆医療提供者、実験室）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況など、以下の構成でお届けします。なお、本書には、Abbott Laboratories、Alere, Inc.、ARKRAY, Inc.、Beckman Coulter, Inc.、Bio-Rad Laboratories, Inc.、Diazyme Laboratories, Inc.、EKF Diagnostics Holdings Plc、HemoCue AB、Menarini Diagnostics Ltd.、OSANG Healthcare Co., Ltd、PTS Diagnostics、Roche Diagnostics、Siemens Healthineers、Tosoh Bioscience, Inc.、Trinity Biotech plcなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のヘモグロビンA1c分析装置市場規模：製品別 - ベンチトップ型分析装置の市場規模 - 携帯型分析装置の市場規模 - 試薬＆消耗品の市場規模 - 検査キットの市場規模 ・世界のヘモグロビンA1c分析装置市場規模：技術別 - 化学的方法における市場規模 - 分離方法における市場規模 ・世界のヘモグロビンA1c分析装置市場規模：種類別 - HbA1c臨床検査の市場規模 - HbA1c PoC検査の市場規模 ・世界のヘモグロビンA1c分析装置市場規模：エンドユーザー別 - 学術＆研究機関における市場規模 - 病院＆医療提供者における市場規模 - 実験室における市場規模 ・世界のヘモグロビンA1c分析装置市場規模：地域別 - 南北アメリカのヘモグロビンA1c分析装置市場規模 アメリカのヘモグロビンA1c分析装置市場規模 カナダのヘモグロビンA1c分析装置市場規模 ブラジルのヘモグロビンA1c分析装置市場規模 ... - アジア太平洋のヘモグロビンA1c分析装置市場規模 日本のヘモグロビンA1c分析装置市場規模 中国のヘモグロビンA1c分析装置市場規模 インドのヘモグロビンA1c分析装置市場規模 韓国のヘモグロビンA1c分析装置市場規模 台湾のヘモグロビンA1c分析装置市場規模 ... - ヨーロッパ/中東/アフリカのヘモグロビンA1c分析装置市場規模 イギリスのヘモグロビンA1c分析装置市場規模 ドイツのヘモグロビンA1c分析装置市場規模 インドのヘモグロビンA1c分析装置市場規模 フランスのヘモグロビンA1c分析装置市場規模 ロシアのヘモグロビンA1c分析装置市場規模 ... - その他地域のヘモグロビンA1c分析装置市場規模 ・競争状況 ・企業情報 |
The Global Hemoglobin A1c Analyzer Market size was estimated at USD 344.32 million in 2021 and expected to reach USD 379.93 million in 2022, and is projected to grow at a CAGR 10.51% to reach USD 627.40 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Hemoglobin A1c Analyzer to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Bench-top Analyzers, Handheld Analyzers, Reagents and Consumables, and Test Kits.
Based on Technology, the market was studied across Chemical Methods and Separation Methods. The Chemical Methods is further studied across Chemical Methods, Enzymatic Assays, and Immunoassays. The Separation Methods is further studied across Affinity Chromatography, Capillary Electrophoresis, and HPLC Ion Exchange.
Based on Type, the market was studied across HbA1c Laboratory Testing and HbA1c Point of Care Testing.
Based on End User, the market was studied across Academic & Research Institutes, Hospitals & Care Providers, and Laboratories.
Based on Distribution Channel, the market was studied across Offline Mode and Online Mode.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Hemoglobin A1c Analyzer market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Hemoglobin A1c Analyzer Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Hemoglobin A1c Analyzer Market, including Abbott Laboratories, Alere, Inc., ARKRAY, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Diazyme Laboratories, Inc., EKF Diagnostics Holdings Plc, HemoCue AB, Menarini Diagnostics Ltd., OSANG Healthcare Co., Ltd, PTS Diagnostics, Roche Diagnostics, Siemens Healthineers, Tosoh Bioscience, Inc., and Trinity Biotech plc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Hemoglobin A1c Analyzer Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Hemoglobin A1c Analyzer Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Hemoglobin A1c Analyzer Market?
4. What is the competitive strategic window for opportunities in the Global Hemoglobin A1c Analyzer Market?
5. What are the technology trends and regulatory frameworks in the Global Hemoglobin A1c Analyzer Market?
6. What is the market share of the leading vendors in the Global Hemoglobin A1c Analyzer Market?
7. What modes and strategic moves are considered suitable for entering the Global Hemoglobin A1c Analyzer Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of diabetes and other lifestyle diseases
5.1.1.2. Rising healthcare concern along with public awareness about preventive care
5.1.1.3. Introducing cost-effective HbA1c tests and devices
5.1.2. Restraints
5.1.2.1. Genetic variants, elevated fetal hemoglobin (HbF) and chemically modified derivatives of hemoglobin can affect the accuracy of HbA1c measurements
5.1.2.2. High cost and time-consuming process
5.1.3. Opportunities
5.1.3.1. Technological advancements to develop devices with superior precision
5.1.3.2. Increased support by the government in the developing economies
5.1.4. Challenges
5.1.4.1. Preference towards alternative testing such as glycated serum protein or glycated albumin testing
5.2. Cumulative Impact of COVID-19
6. Hemoglobin A1c Analyzer Market, by Product
6.1. Introduction
6.2. Bench-top Analyzers
6.3. Handheld Analyzers
6.4. Reagents and Consumables
6.5. Test Kits
7. Hemoglobin A1c Analyzer Market, by Technology
7.1. Introduction
7.2. Chemical Methods
7.3.1. Chemical Methods
7.3.2. Enzymatic Assays
7.3.3. Immunoassays
7.3. Separation Methods
7.4.1. Affinity Chromatography
7.4.2. Capillary Electrophoresis
7.4.3. HPLC Ion Exchange
8. Hemoglobin A1c Analyzer Market, by Type
8.1. Introduction
8.2. HbA1c Laboratory Testing
8.3. HbA1c Point of Care Testing
9. Hemoglobin A1c Analyzer Market, by End User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Hospitals & Care Providers
9.4. Laboratories
10. Hemoglobin A1c Analyzer Market, by Distribution Channel
10.1. Introduction
10.2. Offline Mode
10.3. Online Mode
11. Americas Hemoglobin A1c Analyzer Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Hemoglobin A1c Analyzer Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Hemoglobin A1c Analyzer Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Abbott Laboratories
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. Alere, Inc.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. ARKRAY, Inc.
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Beckman Coulter, Inc.
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Bio-Rad Laboratories, Inc.
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Diazyme Laboratories, Inc.
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. EKF Diagnostics Holdings Plc
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. HemoCue AB
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Menarini Diagnostics Ltd.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. OSANG Healthcare Co., Ltd
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. PTS Diagnostics
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Roche Diagnostics
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Siemens Healthineers
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Tosoh Bioscience, Inc.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Trinity Biotech plc
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing